SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000925421-17-000354
Filing Date
2017-09-25
Accepted
2017-09-25 16:55:51
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 3305
  Complete submission text file 0000925421-17-000354.txt   4900
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address POLARISAVENUE 87 2132 JH HOOFDDORP P7 00000
Business Address POLARISAVENUE 87 2132 JH HOOFDDORP P7 00000 (609) 819-8200
Sun Pharma (Netherlands) B.V. (Reporting) CIK: 0001717322 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 0331
Type: 3/A | Act: 34 | File No.: 001-38210 | Film No.: 171100317